Tinzaparin sodium for thrombosis treatment and prevention during pregnancy

Article Abstract:

A study to assess the pharmacodynamic profile, safety and efficacy of tinzaparin during pregnancy is conducted on 54 pregnant women-12 for thrombosis treatment and 42 for thromboprophylaxis treatment. The 175 anti-Xa U/Kg dose is appropriate for high-risk thromboprophylaxis in pregnancy, where as a 75 anti-Xa U/Kg dose is appropriate for moderate-risk thromboprophylaxis in pregnancy.

United Kingdom, Thrombosis, Blood clot, Pharmacokinetics, Tinzaparin

---

L-arginine erythrocyte transport increases during pregnancy and immediately postpartum

Article Abstract:

A study focuses on evaluating erythrocyte membrane transport of L-arginine in pregnancy and immediately postpartum. The results indicate that total erythrocyte L-arginine uptake (maximum transport capacity and half-saturation constant) increases progressively along normal pregnancy, with a further increase immediately postpartum.

Biological transport, Erythrocytes, Red blood cells, Cohort analysis

---

Obstetric outcomes associated with increase in BMI category during pregnancy

Article Abstract:

The objective of the study was to investigate the effect of increase in body mass index (BMI) category on perinatal complications. Reported that the risk of preeclampsia typically doubled with each 5 to 7 kg/m(super 2) increase in prepregnancy BMI.

Analysis, Composition, Body mass index, Perinatology, Obstetrical diagnosis

Similar abstracts:

• Abstracts: Postinfarction risk stratification: is preventive war winnable? Risk of myocardial infarction in patients with psoriasis
• Abstracts: Trouble at sea. Malaria: It causes, treatment and methods of prevention
• Abstracts: Cochlear implantation for the treatment of deafness. Emerging infectious threats to the blood supply
• Abstracts: Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. RNAi quashes polyQ
• Abstracts: Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.